Advisor Group Holdings, Inc. Beam Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

  • $39.8 Billion
  • Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,649 shares of BEAM stock, worth $96,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,649
Previous 13,591 73.15%
Holding current value
$96,406
Previous $332,000 72.89%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
SELL
$21.55 - $30.35 $214,250 - $301,739
-9,942 Reduced 73.15%
3,649 $90,000
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $15,144 - $22,236
671 Added 5.19%
13,591 $332,000
Q2 2024

Aug 13, 2024
SELL
$21.22 - $32.66 $22,238 - $34,227
-1,048 Reduced 7.5%
12,920 $302,000
Q1 2024

May 10, 2024
SELL
$23.46 - $45.07 $64,421 - $123,762
-2,746 Reduced 16.43%
13,968 $461,000
Q4 2023

Feb 12, 2024
BUY
$17.69 - $30.76 $59,686 - $103,784
3,374 Added 25.29%
16,714 $454,000
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $5,246 - $7,400
228 Added 1.74%
13,340 $320,000
Q2 2023

Aug 10, 2023
SELL
$29.32 - $35.99 $11,991 - $14,719
-409 Reduced 3.02%
13,112 $418,000
Q1 2023

May 12, 2023
SELL
$30.15 - $48.79 $21,738 - $35,177
-721 Reduced 5.06%
13,521 $414,000
Q4 2022

Feb 10, 2023
BUY
$36.73 - $51.6 $89,731 - $126,058
2,443 Added 20.71%
14,242 $557,000
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $122,951 - $217,257
-3,090 Reduced 20.75%
11,799 $561,000
Q2 2022

Aug 10, 2022
BUY
$29.86 - $62.36 $12,481 - $26,066
418 Added 2.89%
14,889 $578,000
Q1 2022

May 04, 2022
SELL
$53.73 - $82.16 $271,229 - $414,743
-5,048 Reduced 25.86%
14,471 $823,000
Q3 2021

Nov 05, 2021
BUY
$84.37 - $133.6 $203,584 - $322,376
2,413 Added 14.11%
19,519 $1.7 Million
Q2 2021

Aug 02, 2021
BUY
$64.12 - $128.71 $263,404 - $528,740
4,108 Added 31.6%
17,106 $2.21 Million
Q1 2021

May 13, 2021
BUY
$71.28 - $120.75 $300,231 - $508,599
4,212 Added 47.94%
12,998 $1.04 Million
Q4 2020

Feb 10, 2021
SELL
$22.24 - $95.63 $8,651 - $37,200
-389 Reduced 4.24%
8,786 $717,000
Q3 2020

Nov 12, 2020
BUY
$19.0 - $30.57 $2,850 - $4,585
150 Added 1.66%
9,175 $226,000
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $137,721 - $258,656
9,025 New
9,025 $253,000

Others Institutions Holding BEAM

# of Institutions
253
Shares Held
78.6M
Call Options Held
304K
Put Options Held
142K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.86B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email